Lowering Brain Fluid Leaks in Idiopathic Intracranial Hypertension Using GLP-1 Receptor Agonists

A significant reduction in elevated intracranial pressure (ICP) may be achieved with glucagon-like peptide-1 (GLP-1) receptor agonists.

• Elevated ICP is linked to an increased risk of cerebrospinal fluid (CSF) leaks.
• Idiopathic intracranial hypertension (IIH) is associated with elevated ICP.
• GLP-1 receptor agonists have shown potential in lowering ICP in patients with IIH.
• The study aims to assess how GLP-1 agonists may affect the occurrence of CSF leaks.

Simplified